StockData
Zymeworks Inc. logo

Zymeworks Inc. (ZYME) stock

ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30667% above fair value
$26.04+0.20 (+0.77%)

Close on Nov 18, 2026Market cap $1.85BP/E –Yield –

Zymeworks net income

Net income is the profit left for shareholders after every expense, interest and tax.

Zymeworks's net income for the twelve months ending Jun 30, 2026 was -$149.99M. For fiscal 2025 it was -$81.13M. The highest annual figure on record is $124.34M in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$81.13M–
FY2024Dec 31, 2024-$122.70M–
FY2023Dec 31, 2023-$118.67M-195.4%
FY2022Dec 31, 2022$124.34M–
FY2021Dec 31, 2021-$211.84M–
FY2020Dec 31, 2020-$180.55M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$45.02M-2043.0%
Q1 FY2026Mar 31, 2026-$44.16M–
Q4 FY2025Dec 31, 2025-$41.21M–
Q3 FY2025Sep 30, 2025-$19.60M–
Q2 FY2025Jun 30, 2025$2.32M–
Q1 FY2025Mar 31, 2025-$22.64M–
Q4 FY2024Dec 31, 2024-$23.51M–
Q3 FY2024Sep 30, 2024-$29.85M–
Q2 FY2024Jun 30, 2024-$37.69M–
Q1 FY2024Mar 31, 2024-$31.65M–
Q4 FY2023Dec 31, 2023-$14.48M-104.7%
Q3 FY2023Sep 30, 2023-$28.69M–
Q2 FY2023Jun 30, 2023-$51.15M–
Q1 FY2023Mar 31, 2023-$24.35M–
Q4 FY2022Dec 31, 2022$309.43M–
Q3 FY2022Sep 30, 2022-$47.85M–
Q2 FY2022Jun 30, 2022-$64.62M–
Q1 FY2022Mar 31, 2022-$72.63M–
Q4 FY2021Dec 31, 2021-$39.15M–
Q3 FY2021Sep 30, 2021-$60.58M–
Q2 FY2021Jun 30, 2021-$67.52M–
Q1 FY2021Mar 31, 2021-$44.59M–

More Zymeworks figures

See a number that looks wrong?